Olutasidenib
C-002102-003
Approved small_molecule active
Quick answer
Olutasidenib for AML (Acute Myeloid Leukemia) is a Approved program (small_molecule) at RIGEL PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- RIGEL PHARMACEUTICALS INC
- Indication
- AML (Acute Myeloid Leukemia)
- Phase
- Approved
- Modality
- small_molecule
- Status
- active